The lymphoma program consists of clinicians, pathologists and radiologists at the OUH Radiumhospitalet and basic scientists at the Department of Cancer Immunology at the Institute for Cancer Research OUH - Dept. of Cancer Immunology (ous-research.no) with dedication for malignant lymphomas. Together we aim to provide optimal care and treatment for our patients, possibilities to participate in relevant clinical studies as well as translational and molecular/biological lymphoma research. Clinicians in charge of the research activities constitute the Lymphoma research group.

We have broad national and international cooperation with i.e. the Nordic Lymphoma Group Home - Nordic-lymphoma : Nordic-lymphoma and other European study groups like the German Lymphoma  Alliance (GLA) German Lymphoma Alliance (german-lymphoma-alliance.de), German Hodgkin Study Group (GHSG) Home - GHSG - German Hodgkin Study Group, British National Lymphoma Investigation (BNLI) ctc.ucl.ac.uk,  the European Bone Marrow Transplantation Group (EBMT) Discover more at EBMT, the Norwegian Cancer Registry (Kreftregisteret) and European Organisation for Research and Treatment of Cancer (EORTC) European Organisation For Research And Treatment Of Cancer - EORTC. The Norwegian Radium Hospital is one of three European Hospitals which are members of the Lymphoma and Leukemia Molecular Profiling Project (LLMPP), headed by National Cancer Institute, USA LymphoChip microarray Gene Expression Gateway (nih.gov). 

We are open to collaborations both with academic and industry partners. 

Together, we are currently supervising 5 PhD students as main or co-supervisors.